Related Experiment Video
Updated: Jun 22, 2026
10:28
Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018
Maternal serum adiponectin multimers in gestational diabetes
Shali Mazaki-Tovi1, Roberto Romero, Edi Vaisbuch
1Perinatology Research Branch, Intramural Division, NICHD/NIH/DHHS, Hutzel Women's Hospital, Detroit, MI 48201, USA.
Journal of Perinatal Medicine
|June 18, 2009
Summary
Gestational diabetes mellitus (GDM) is linked to altered adiponectin multimers, similar to Type 2 diabetes. These changes in low-molecular-weight (LMW), medium-molecular-weight (MMW), and high-molecular-weight (HMW) adiponectin may explain the connection between obesity and GDM.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Reproductive Health
Background:
- Adiponectin, an insulin-sensitizing adipokine, exists in various multimeric forms (LMW, MMW, HMW) with distinct biological effects.
- Understanding adiponectin multimer dynamics is crucial for metabolic health, particularly in pregnancy.
Purpose of the Study:
- To investigate changes in circulating adiponectin multimer profiles in gestational diabetes mellitus (GDM).
- To examine the influence of overweight/obesity and GDM treatments (sulfonylurea or insulin) on adiponectin multimers.
Main Methods:
- A cross-sectional study comparing women with normal pregnancies (n=149) and GDM (n=72).
- Stratification by BMI (<25 kg/m² vs. ≥25 kg/m²) and GDM treatment (diet, Glyburide, or insulin).
- Serum adiponectin multimer concentrations (total, HMW, MMW, LMW) measured by ELISA.
Main Results:
- Patients with GDM exhibited lower total, HMW, MMW, and LMW adiponectin levels compared to normal pregnancies.
- GDM was associated with a reduced HMW/total adiponectin ratio and increased MMW/total and LMW/total ratios.
- No significant differences in adiponectin multimer profiles were observed between GDM patients treated with diet versus pharmacological agents.
Conclusions:
- GDM presents a unique adiponectin multimer pattern, resembling that of Type 2 diabetes mellitus.
- Adiponectin multimer dysregulation may offer a mechanistic link between adiposity and the development of GDM.
Related Concept Videos
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...